Results 141 to 150 of about 43,282 (217)

Digitalization and organizational capabilities: a mechanism-based integrative review. [PDF]

Front Psychol
Jia S, Khaw KW, Zhou Y.
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Shaping Circularity in the Food Industry: Strategic Pillars Enabled by Biorefinery Systems. [PDF]

Foods
Espuny M, Oliveira Maia AL, Poltronieri CF, Carvalho CP, Oliveira OJ.   +4 more
europepmc   +1 more source

Business Cycle Measurement [PDF]

, 2008
Don Harding, Adrian Pagan
openaire   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Industry-academia interface: how to build industry-university partnerships with Mark Jefferies. [PDF]

Commun Eng
europepmc   +1 more source

Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance. [PDF]

Cancer Med
Kikuchi E, Nagata M, Ito T, Sato M, Ogi M, Morita M, Kajita M, Nishiyama H.   +7 more
europepmc   +1 more source

Reception Baseline Assessment and ‘small acts’ of micro‐resistance

British Educational Research Journal, EarlyView.
Abstract In September 2021, following the global COVID‐19 pandemic, the Department for Education introduced a national standardised digital Reception Baseline Assessment (RBA) for all English 4‐year‐old children. We analyse RBA and its associated Quality Monitoring Visits, as a further intensification of the new public management of early years ...
Guy Roberts‐Holmes, Diana Sousa, Siew Fung Lee   +2 more
wiley   +1 more source

Hydrothermally Synthesized Mn₂V₂O₇ Nanopebble-Decorated ZIF-67: A Promising Cathode Material for Energy Storage Applications. [PDF]

ACS Omega
Sanjana S, Siva V, Murugan A, Shameem AS, Sahadevan J, Jauhar RM, Padmavathi K, Vasudevan A.   +7 more
europepmc   +1 more source